Skip to content
★ Sign in to follow
LF

Lisa French

Mallinckrodt plcKeenova Therapeutics plc
Total declarations
8
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 05 Jan 2026 for Keenova Therapeutics plc.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

No signal scores available.

Lisa French: trading record in brief

All filings by Lisa French on record concern Mallinckrodt plc. Between 14 December 2022 and 1 January 2026, the trades on record add up to 8 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

On 5 January 2026 came the latest disclosure, a share grant in Mallinckrodt plc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Lisa French

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total
  • ◇
    EVP & Chief Commercial OfficerExecutivesKeenova Therapeutics plc
    0SEC
    6,576 sharesOrdinary SharesSEC:0001104659-26-000780:0
  • ◆
    EVP & Chief Commercial OfficerExecutivesMallinckrodt plc
    0SEC
    1,670 sharesOrdinary SharesSEC:0001104659-25-004588:0
  • ◇
    EVP & Chief Commercial OfficerExecutivesMallinckrodt plc
    0SEC
    5,470 sharesOrdinary SharesSEC:0001104659-25-000370:0
  • ●
    EVP & Chief Commercial OfficerExecutivesMallinckrodt plc
    0SEC
    64,455 shares0Ordinary SharesSEC:0001104659-23-119114:0
  • ◆
    EVP & Chief Commercial OfficerExecutivesMallinckrodt plc
    904 USD19SEC
    10,636 shares@ US$0.085100.0% of flowOrdinary SharesSEC:0001104659-23-105918:0
  • ◆
    EVP & Chief Commercial OfficerExecutivesMallinckrodt plc
    0SEC
    75,091 shares0Ordinary SharesSEC:0001104659-22-129620:0

6 of 6 declarations